Acitretin in psoriasis: An overview of adverse effects

Journal of the American Academy of Dermatology

Volumn 41, Issue 3 SUPPL., 1999, Pages

  Katz, H I ^a   Waalen, J ^a   Leach, E E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; ETRETINATE; RETINOID;

BRAIN PSEUDOTUMOR; CHEILITIS; CLINICAL TRIAL; CONFERENCE PAPER; DRUG POTENTIATION; HAIR LOSS; HUMAN; HYPERLIPIDEMIA; HYPEROSTOSIS; LIVER TOXICITY; ORAL DRUG ADMINISTRATION; PANCREATITIS; PRIORITY JOURNAL; PSORIASIS; TERATOGENICITY;

EID: 0032880394     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70359-2     Document Type: Conference Paper

References (28)

1. JM Geiger JH Saurat Acitretin and etretinate. How and when they should be used Dermatol Clin 11 1993 117 129
2. CE Orfanos CC Zouboulis B Almond-Roesler CC Geilen Current use and future potential role of retinoids in dermatology Drugs 53 1997 358 388
3. JH Saurat Systemic retinoids. What’s new? Dermatol Clin 16 1998 331 340
4. CJ Brindley An overview of recent clinical pharmacokinetic studies with acitretin (Ro-1670, etretin) Dermatologica 178 1989 79 87
5. FG Larsen P Jakobsen CG Larsen Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients Pharmacol Toxicol 62 1988 159 165
6. JJ Di Giovanna LA Zech ME Ruddel Etretinate. Persistent serum levels after long-term therapy Arch Dermatol 125 1989 246 251
7. Soriatane [package insert] 1997 Roche Laboratories Nutley, NJ
8. UW Wiegand RC Chou Pharmacokinetics of acitretin and etretinate J Am Acad Dermatol 39 1998 S25 S33
9. FG Larsen P Jakobsen J Knudsen K Weismann K Kragballe F Nielsen-Kudsk Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol J Invest Dermatol 100 1993 623 627
10. RC Chou R Wyss CA Huselton UW Wiegand A potentially new metabolic pathway: ethyl esterification of acitretin Xenobiotica 22 1992 993 1002
11. JP Laugier G De Sousa H Bun JM Geiger C Surber R Rahmani Acitretin biotransformation into etretinate: role of ethanol on in vitro hepatic metabolism Dermatology 188 1994 122 125
12. PJ McNamara RC Jewell BK Jensen CJ Brindley Food increases the bioavailability of acitretin J Clin Pharmacol 28 1988 1051 1055
13. EJ Lammer DT Chen RM Hoar Retinoic acid embryopathy N Engl J Med 313 1985 837 841
14. EJ Lammer Developmental toxicity of synthetic retinoids in humans Prog Clin Biol Res 281 1988 193 202
15. CE de Die-Smulders MC Studenboom J Veraart C van Katwijk P Sastrowijoto E van der Linden Severe limb defects and craniofacial anomalies in a fetus conceived during acitretin therapy Teratology 52 1995 215 219
16. Roche Laboratories, data on file.
17. B Löfberg J Reiners H Spielmann Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapy Dev Pharmacol Ther 15 1990 45 51
18. TJ van Ditzhuijsen UJ van Haelst RJ van Dooren-Greebe PC van de Kerkhof SH Yap Severe hepatotoxic reaction with progression to cirrhosis after use of a novel retinoid (acitretin) J Hepatol 11 1990 185 188
19. C Lubetzki M Sanson D Cohen M Schaison-Cusin FL-CO Lhermitte Benign intracranial hypertension and minocycline (see comments) [French] Revue Neurologique 144 1988 218 220
20. Y Moskowitz E Leibowitz M Ronen E Aviel Pseudotumor cerebri induced by vitamin A combined with minocycline Ann Ophthalmol 25 1993 306 308
21. AK Gupta MT Goldfarb CN Ellis JJ Voorhees Side-effect profile of acitretin therapy in psoriasis J Am Acad Dermatol 20 1989 1088 1093
22. T Pilkington RN Brodgen Acitretin. A review of its pharmacology and therapeutic use Drugs 43 1992 597 627
23. C Vahlquist AG Olsson A Lindholm A Vahlquist Effects of gemfibrozil (Lopid) on hyperlipidemia in acitretin-treated patients: results of a double-blind cross-over study Acta Dermatol Venereol 75 1995 377 380
24. RS Stern E Fitzgerald CN Ellis N Lowe MT Goldfarb RD Baughman The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study J Am Acad Dermatol 33 1995 44 52
25. HP Gollnick Oral retinoids: efficacy and toxicity in psoriasis Br J Dermatol 135 suppl 49 1996 6 17
26. RJ van Dooren-Greebe JA Lemmens T De Boo NM Hangx AL Kuijpers PC van de Kerkhof Prolonged treatment with oral retinoids in adults: no influence on the frequency and severity of spinal abnormalities Br J Dermatol 134 1996 71 76
27. HI Katz Acitretin HI Katz Guide to adverse treatment interactions for skin, hair, and nail disorders 1998 Lippincott-Raven Publishers Philadelphia 8 9
28. P Berbis H Bun JM Geiger Acitretin (RO10-1670) and oral contraceptives: interaction study Arch Dermatol Res 280 1988 388 389